{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T14:57:17Z","timestamp":1790693837812,"version":"4.1.0"},"reference-count":31,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2027,5,1]],"date-time":"2027-05-01T00:00:00Z","timestamp":1809129600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2027,5,1]],"date-time":"2027-05-01T00:00:00Z","timestamp":1809129600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,7,22]],"date-time":"2026-07-22T00:00:00Z","timestamp":1784678400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["valuehealthregionalissues.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Value in Health Regional Issues"],"published-print":{"date-parts":[[2027,5]]},"DOI":"10.1016\/j.vhri.2026.101695","type":"journal-article","created":{"date-parts":[[2026,8,19]],"date-time":"2026-08-19T11:42:09Z","timestamp":1787139729000},"page":"101695","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Development and Psychometric Validation of the TF-Col: A Patient- and Caregiver-Reported Measure of Financial Toxicity in Oncology"],"prefix":"10.1016","volume":"59","author":[{"given":"Julio C\u00e9sar","family":"S\u00e1nchez-Ar\u00e9valo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fabio Alexander","family":"Sierra-Matamoros","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marcela","family":"P\u00e9rez Sosa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Diana Isabel","family":"Cu\u00e9llar Rivera","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ricardo S\u00e1nchez","family":"Pedraza","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"2","key":"10.1016\/j.vhri.2026.101695_bib1","first-page":"80","article-title":"Financial toxicity, part I: a new name for a growing problem","volume":"27","author":"Zafar","year":"2013","journal-title":"Oncology (Williston Park)"},{"issue":"9","key":"10.1016\/j.vhri.2026.101695_bib2","doi-asserted-by":"crossref","DOI":"10.21037\/atm.2018.03.28","article-title":"Financial toxicity and implications for cancer care in the era of molecular and immune therapies","volume":"6","author":"Tran","year":"2018","journal-title":"Ann Transl Med"},{"issue":"9","key":"10.1016\/j.vhri.2026.101695_bib3","doi-asserted-by":"crossref","first-page":"1375","DOI":"10.1016\/j.bbmt.2014.05.011","article-title":"Financial burden in recipients of allogeneic hematopoietic cell transplantation","volume":"20","author":"Khera","year":"2014","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.vhri.2026.101695_bib4","doi-asserted-by":"crossref","DOI":"10.1590\/1518-8345.6688.3996","article-title":"Quality of life and financial toxicity of hematopoietic stem cell transplant recipients in COVID-19","volume":"31","author":"Oshiro","year":"2023","journal-title":"Rev Lat Am Enfermagem"},{"issue":"11","key":"10.1016\/j.vhri.2026.101695_bib5","doi-asserted-by":"crossref","first-page":"2043","DOI":"10.1093\/tbm\/ibab091","article-title":"Financial toxicity in cancer care: origins, impact, and solutions","volume":"11","author":"Abrams","year":"2021","journal-title":"Transl Behav Med"},{"issue":"4","key":"10.1016\/j.vhri.2026.101695_bib6","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1200\/JCO.19.01564","article-title":"Understanding financial hardship among cancer survivors in the United States: strategies for prevention and mitigation","volume":"38","author":"Yabroff","year":"2020","journal-title":"J Clin Oncol"},{"issue":"2","key":"10.1016\/j.vhri.2026.101695_bib7","doi-asserted-by":"crossref","DOI":"10.1136\/bmjgh-2024-017133","article-title":"The financial toxicity of cancer: unveiling global burden and risk factors \u2013 a systematic review and meta-analysis","volume":"10","author":"Kitaw","year":"2025","journal-title":"BMJ Glob Health"},{"issue":"1","key":"10.1016\/j.vhri.2026.101695_bib8","first-page":"36","article-title":"Financial toxicity among pediatric oncology families during therapy and early survivorship: a qualitative analysis","volume":"33","author":"Ohlsen","year":"2024","journal-title":"Support Care Cancer"},{"issue":"7","key":"10.1016\/j.vhri.2026.101695_bib9","doi-asserted-by":"crossref","first-page":"1061","DOI":"10.1093\/annonc\/mdz140","article-title":"Methods for measuring financial toxicity after cancer .diagnosis and treatment: a systematic review and its implications","volume":"30","author":"Witte","year":"2019","journal-title":"Ann Oncol"},{"issue":"20","key":"10.1016\/j.vhri.2026.101695_bib10","doi-asserted-by":"crossref","first-page":"3245","DOI":"10.1002\/cncr.28814","article-title":"The development of a financial toxicity patient-reported outcome in cancer: the COST measure","volume":"120","author":"De Souza","year":"2014","journal-title":"Cancer"},{"issue":"3","key":"10.1016\/j.vhri.2026.101695_bib11","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1002\/cncr.30369","article-title":"Measuring financial toxicity as a clinically relevant patient-reported outcome: the validation of the comprehensive Score for financial Toxicity (COST)","volume":"123","author":"de Souza","year":"2017","journal-title":"Cancer"},{"issue":"9","key":"10.1016\/j.vhri.2026.101695_bib12","first-page":"7159","article-title":"Financial toxicity of cancer care in low- and middle-income countries: a systematic review and meta-analysis","volume":"30","author":"Donkor","year":"2022","journal-title":"Support Care Cancer"},{"issue":"6","key":"10.1016\/j.vhri.2026.101695_bib13","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2023.19317","article-title":"Family and caregiver financial toxicity associated with cancer - A global, inequitable, and urgent consideration","volume":"6","author":"Dee","year":"2023","journal-title":"JAMA Netw Open"},{"issue":"2","key":"10.1016\/j.vhri.2026.101695_bib14","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/j.pse.2014.11.003","article-title":"An introduction to the use of evidence-centered design in test development","volume":"20","author":"Zieky","year":"2014","journal-title":"Psicol Educ (Madr)"},{"key":"10.1016\/j.vhri.2026.101695_bib15","series-title":"A Brief Introduction to Evidence-Centered Design","author":"Mislevy","year":"2003"},{"key":"10.1016\/j.vhri.2026.101695_bib16","series-title":"Evidence-Centered Assessment Design: Layers, Structures, and Terminology","author":"Mislevy","year":"2005"},{"issue":"5","key":"10.1016\/j.vhri.2026.101695_bib17","doi-asserted-by":"crossref","first-page":"1159","DOI":"10.1007\/s11136-018-1829-0","article-title":"COSMIN methodology for evaluating the content validity of patient-reported outcome measures: a Delphi study","volume":"27","author":"Terwee","year":"2018","journal-title":"Qual Life Res"},{"key":"10.1016\/j.vhri.2026.101695_bib18","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1007\/s11336-008-9102-z","article-title":"Coefficients alpha, beta, omega, and the glb: comments on Sijtsma","volume":"74","author":"Revelle","year":"2009","journal-title":"Psychometrika"},{"issue":"7","key":"10.1016\/j.vhri.2026.101695_bib19","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1016\/j.jclinepi.2010.02.006","article-title":"The COSMIN study reached international consensus on taxonomy, terminology, and definitions of measurement properties for health-related patient-reported outcomes","volume":"63","author":"Mokkink","year":"2010","journal-title":"J Clin Epidemiol"},{"issue":"3","key":"10.1016\/j.vhri.2026.101695_bib20","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1037\/a0029315","article-title":"When can categorical variables be treated as continuous? A comparison of robust continuous and categorical SEM estimation methods under suboptimal conditions","volume":"17","author":"Rhemtulla","year":"2012","journal-title":"Psychol Methods"},{"issue":"1","key":"10.1016\/j.vhri.2026.101695_bib21","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1007\/s11135-008-9190-y","article-title":"Polychoric versus Pearson correlations in exploratory and confirmatory factor analysis of ordinal variables","volume":"44","author":"Holgado-Tello","year":"2010","journal-title":"Qual Quant"},{"issue":"3","key":"10.1016\/j.vhri.2026.101695_bib22","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1037\/1082-989X.4.3.272","article-title":"Evaluating the use of exploratory factor analysis in psychological research","volume":"4","author":"Fabrigar","year":"1999","journal-title":"Psychol Methods"},{"issue":"6","key":"10.1016\/j.vhri.2026.101695_bib23","doi-asserted-by":"crossref","first-page":"806","DOI":"10.1177\/0011000006288127","article-title":"Scale development research: a content analysis and recommendations for best practices","volume":"34","author":"Worthington","year":"2006","journal-title":"Couns Psychol"},{"issue":"S1","key":"10.1016\/j.vhri.2026.101695_bib24","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/BF03372160","article-title":"Estimation of latent ability using a response pattern of graded scores","volume":"34","author":"Samejima","year":"1969","journal-title":"Psychometrika"},{"key":"10.1016\/j.vhri.2026.101695_bib25","series-title":"Item Response Theory for Psychologists","author":"Embretson","year":"2000"},{"key":"10.1016\/j.vhri.2026.101695_bib26","series-title":"Confirmatory Factor Analysis for Applied Research","author":"Brown","year":"2015"},{"issue":"4","key":"10.1016\/j.vhri.2026.101695_bib27","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1007\/BF02296192","article-title":"A scaled difference chi-square test statistic for moment structure analysis","volume":"66","author":"Satorra","year":"2001","journal-title":"Psychometrika"},{"issue":"6","key":"10.1016\/j.vhri.2026.101695_bib28","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1080\/00223891.2010.496477","article-title":"Bifactor models and rotations: exploring the extent to which multidimensional data yield univocal scale scores","volume":"92","author":"Reise","year":"2010","journal-title":"J Pers Assess"},{"key":"10.1016\/j.vhri.2026.101695_bib29","doi-asserted-by":"crossref","DOI":"10.1016\/j.jcpo.2021.100272","article-title":"The financial impact of a terminal cancer on patient\u2019s families in Colombia \u2013 A survey study","volume":"28","author":"de Vries","year":"2021","journal-title":"J Cancer Policy"},{"issue":"9","key":"10.1016\/j.vhri.2026.101695_bib30","doi-asserted-by":"crossref","first-page":"1092","DOI":"10.1634\/theoncologist.2015-0026","article-title":"Financial distress and its associations with physical and emotional symptoms and quality of life among advanced cancer patients","volume":"20","author":"Delgado-Guay","year":"2015","journal-title":"Oncologist"},{"issue":"9","key":"10.1016\/j.vhri.2026.101695_bib31","doi-asserted-by":"crossref","first-page":"e364","DOI":"10.1016\/S1470-2045(23)00320-0","article-title":"Financial hardship in families of children or adolescents with cancer: a systematic literature review","volume":"24","author":"Ritter","year":"2023","journal-title":"Lancet Oncol"}],"container-title":["Value in Health Regional Issues"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S221210992600110X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S221210992600110X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T14:02:19Z","timestamp":1790690539000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S221210992600110X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2027,5]]},"references-count":31,"alternative-id":["S221210992600110X"],"URL":"https:\/\/doi.org\/10.1016\/j.vhri.2026.101695","relation":{},"ISSN":["2212-1099"],"issn-type":[{"value":"2212-1099","type":"print"}],"subject":[],"published":{"date-parts":[[2027,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Development and Psychometric Validation of the TF-Col: A Patient- and Caregiver-Reported Measure of Financial Toxicity in Oncology","name":"articletitle","label":"Article Title"},{"value":"Value in Health Regional Issues","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vhri.2026.101695","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier Inc. on behalf of International Society for Pharmacoeconomics and Outcomes Research, Inc.","name":"copyright","label":"Copyright"}],"article-number":"101695"}}